Clinical studies recruiting near Strasbourg

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · Institut de Cancérologie Strasbourg Europe - Service Hématol · The Lymphoma Academic Research Organisation · NCT07018752 Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus
Phase 3 · Hôpitaux Universitaires de Strasbourg · TBF Genie Tissulaire · NCT06450470 Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Phase 3 · CHU Strasbourg · Fondation Hôpital Saint-Joseph · NCT05674994 New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies
Phase N/A · Service de Virologie - CHU Strasbourg - France · University Hospital, Strasbourg, France · NCT05264259 Clindamycin as Antimicrobial Treatment for Streptococcus Spp. PeRiprosthetic Infection
Phase N/A · Service de Chirurgie Orthopédique Septique - CHU de Strasbou · University Hospital, Strasbourg, France · NCT07335627 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Phase 3 · CHRU Strasbourg Hautepierre · Princess Maxima Center for Pediatric Oncology · NCT05327894 Qualitative Study Exploring the Determinants Involved in the Management of Osteoporosis in Frail Elderly People
Phase N/A · Service de Gériatrie Aiguë - CHU de Strasbourg - France · University Hospital, Strasbourg, France · NCT07303166 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · CHU Strasbourg-Hautepierre · Bristol-Myers Squibb · NCT07106762 Functional, Personalised and Integrated Profiling of Biopsied Pancreatic Tumours (CancerProfile by FNB)
NA · Centre d'Endoscopie Digestive · IHU Strasbourg · NCT06666803 Histological Segmentation of the Superficial Femoral Artery From Microscan to CT Using Artificial Intelligence
NA · Hôpitaux Universitaire de Strasbourg · University Hospital, Strasbourg, France · NCT06260488 A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Centre de recherche en Biomédecine de Strasbourg · Vertex Pharmaceuticals Incorporated · NCT04786262 Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endo
Phase 3 · Clinique Sainte Anne · Gustave Roussy, Cancer Campus, Grand Paris · NCT06712472 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · Hopital Civil / Nouvel Hopital Civil - Strasbourg · University Hospital, Lille · NCT03728049 French Colorectal ESD Cohort in Experts Centers
Phase N/A · CHU de Strasbourg · University Hospital, Limoges · NCT04592003 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
NA · Hopital de Hautepierre · Ad scientiam · NCT05566769 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Nouvel Hôpital Civil · Hospices Civils de Lyon · NCT03593317 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · CHU Strasbourg - Nouvel Hopital Civil · Hoffmann-La Roche · NCT06793215 Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NA · Strasbourg University Hospital · Institut National de la Santé Et de la Recherche Médicale, F · NCT06570278 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centre Hospitalier Regional Universitaire de Strasbourg - Ho · Amgen · NCT07037433 Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers
Phase 2 · Clinique Privée de Strasbourg · Centre Hospitalier Universitaire de Besancon · NCT06425133 Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 3 · Clinical Study Site · Summit Therapeutics · NCT07228832 Impact of a Multi-infusion Strategy in Neonatology on the Rate of Central Line-associated Bloodstream Infections
Phase N/A · Service de néonatologie CHU de Strasbourg · Hospices Civils de Lyon · NCT06656104 Study of Platelet Population Changes Under Circulatory Support With ECMO
Phase N/A · Service d'anesthésie-réanimation - CHU de Strasbourg - Franc · University Hospital, Strasbourg, France · NCT07334457 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · CHU Strasbourg-Hautepierre ( Site 1207) · Merck Sharp & Dohme LLC · NCT07216703 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Hôpitaux Universitaires de Strasbourg · Hospices Civils de Lyon · NCT05444712 COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study
NA · Les Hôpitaux Universitaires de Strasbourg · University Hospital, Strasbourg, France · NCT04461444 Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
Phase 4 · Service SOS Main · University Hospital, Strasbourg, France · NCT06012097 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · CHU Strasbourg · Institut Curie · NCT04731610 Impact of Medicalized Residential Care (LAM) on the Development of Care Plans for Vulnerable Patients in Palliative Care
Phase N/A · Service d'Accompagnement et de Soins Palliatifs - CHU de Str · University Hospital, Strasbourg, France · NCT07342985

Look up another city

Look up another condition